Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Kidney Week 2022: American Society of Nephrology Annual Meeting
November 03 - 06, 2022; Orlando, Florida
November 03 - 06, 2022Orlando, Florida
KidneyWeek 2022EMPA-Kidney Seals SGLT2 Inhibitors as 'Foundational' for CKD Empagliflozin's efficacy in a range of patients with chronic kidney disease in EMPA-Kidney filled evidence gaps and confirmed SGLT2 inhibitors as a key treatment regardless of diabetes status.
Medscape Medical News, November 22, 2022
KidneyWeek 2022Balanced Crystalloid Fluids Surpass Saline for Kidney TransplantLow chloride, balanced-crystalloid IV fluid led to significantly fewer delayed graft function events compared with saline in a multicenter trial of patients getting a deceased-donor kidney transplant.
Medscape Medical News, November 16, 2022
KidneyWeek 2022Dialysis Not Always Best Option in Advanced Kidney Disease Hospitalization rates were higher in advanced chronic kidney disease (CKD) patients treated with dialysis than those managed conservatively over 2 years of follow-up
Oral Daprodustat Safely Improves Anemia in Chronic Kidney DiseasePivotal results from the third agent in a novel drug class showed noninferiority to ESAs for boosting hemoglobin and for most
safety measures in patients with CKD regardless of their dialysis status.
Medscape Medical News, Nov 5, 2021
'Strong Evidence' Oral Steroids Slow IgA Nephropathy ProgressionA 6- to 9-month regimen of oral methylprednisolone showed clear evidence of slowing renal progression of IgA nephropathy,
but safety-driven dose adjustment during the study left the findings uncertain.
